James Burns - Nov 7, 2024 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Signature
/s/ William Cook, as Attorney in Fact for James Burns
Stock symbol
AGIO
Transactions as of
Nov 7, 2024
Transactions value $
-$1,135,775
Form type
4
Date filed
11/12/2024, 04:08 PM
Previous filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGIO Common stock Sale -$697K -13.4K -35.81% $52.00 24K Nov 7, 2024 Direct F1, F2, F3
transaction AGIO Common stock Sale -$438K -8.34K -34.69% $52.56 15.7K Nov 7, 2024 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $51.33 to $52.32. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3 Includes 3,091 shares purchased through the Company's employee stock purchase plan.
F4 The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $52.33 to $52.88. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.